Upcoming Dividend • Apr 29
Upcoming dividend of €1.05 per share Eligible shareholders must have bought the stock before 05 May 2026. Payment date: 07 May 2026. Payout ratio is a comfortable 66% and the cash payout ratio is 80%. Trailing yield: 4.4%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.6%). Annuncio • Apr 17
Interparfums SA to Report First Half, 2026 Results on Sep 09, 2026 Interparfums SA announced that they will report first half, 2026 results on Sep 09, 2026 Declared Dividend • Mar 02
Dividend of €1.05 announced Shareholders will receive a dividend of €1.05. Ex-date: 5th May 2026 Payment date: 7th May 2026 Dividend yield will be 4.3%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by earnings (57% earnings payout ratio) but not covered by cash flows (104% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 3.6% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • Feb 27
Interparfums SA announces Annual dividend, payable on May 07, 2026 Interparfums SA announced Annual dividend of EUR 1.0500 per share payable on May 07, 2026, ex-date on May 05, 2026 and record date on May 06, 2026. Annuncio • Feb 26
Interparfums SA, Annual General Meeting, Apr 24, 2026 Interparfums SA, Annual General Meeting, Apr 24, 2026. New Risk • Jan 23
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.05% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.05% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (104% cash payout ratio). New Risk • Jan 15
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.02% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.02% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (104% cash payout ratio). Valuation Update With 7 Day Price Move • Nov 20
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €22.98, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total loss to shareholders of 38% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €44.39 per share. Annuncio • Oct 18
Interparfums SA to Report Fiscal Year 2025 Results on Feb 25, 2026 Interparfums SA announced that they will report fiscal year 2025 results on Feb 25, 2026 Reported Earnings • Sep 11
First half 2025 earnings released: EPS: €0.87 (vs €0.83 in 1H 2024) First half 2025 results: EPS: €0.87 (up from €0.83 in 1H 2024). Revenue: €446.9m (up 5.8% from 1H 2024). Net income: €73.1m (up 5.0% from 1H 2024). Profit margin: 16% (in line with 1H 2024). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Personal Products industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Annuncio • Jun 05
Interparfums SA to Report Q2, 2025 Results on Sep 09, 2025 Interparfums SA announced that they will report Q2, 2025 results Pre-Market on Sep 09, 2025 Upcoming Dividend • Apr 21
Upcoming dividend of €1.15 per share Eligible shareholders must have bought the stock before 28 April 2025. Payment date: 30 April 2025. Payout ratio is a comfortable 58% and the cash payout ratio is 89%. Trailing yield: 3.1%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (2.4%). Declared Dividend • Mar 14
Dividend of €1.15 announced Shareholders will receive a dividend of €1.15. Ex-date: 28th April 2025 Payment date: 30th April 2025 Dividend yield will be 2.8%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (58% earnings payout ratio) and cash flows (89% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • Mar 14
Interparfums SA announces Annual dividend, payable on April 30, 2025 Interparfums SA announced Annual dividend of EUR 1.1500 per share payable on April 30, 2025, ex-date on April 28, 2025 and record date on April 29, 2025. Annuncio • Mar 12
Interparfums SA, Annual General Meeting, Apr 17, 2025 Interparfums SA, Annual General Meeting, Apr 17, 2025. Location: allee de longchamp, bois de boulogne, paris France Annuncio • Nov 14
Interparfums SA Provides Earnings Guidance for the Years 2024 and 2025 Interparfums SA provided earnings guidance for the years 2024 and 2025. For 2024, the company expects net sales of $1.45 billion or $5.15 diluted per share.
For 2025, the company expects net sales of $1.51 billion or $5.35 diluted per share. Annuncio • Sep 25
Interparfums SA to Report Fiscal Year 2024 Results on Feb 26, 2025 Interparfums SA announced that they will report fiscal year 2024 results on Feb 26, 2025 Buy Or Sell Opportunity • Sep 09
Now 21% undervalued Over the last 90 days, the stock has risen 1.2% to €43.20. The fair value is estimated to be €54.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 34%. For the next 3 years, revenue is forecast to grow by 8.8% per annum. Earnings are also forecast to grow by 9.6% per annum over the same time period. New Risk • Jul 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (224% cash payout ratio). Share price has been volatile over the past 3 months (6.8% average weekly change). Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to €46.05, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 21x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 11% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €40.30 per share. Buy Or Sell Opportunity • May 27
Now 20% overvalued The stock has been flat over the last 90 days, currently trading at €49.65. The fair value is estimated to be €41.27, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 34%. For the next 3 years, revenue is forecast to grow by 8.9% per annum. Earnings are also forecast to grow by 9.4% per annum over the same time period. Upcoming Dividend • Apr 19
Upcoming dividend of €1.15 per share Eligible shareholders must have bought the stock before 26 April 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 64% but the company is paying out more than the cash it is generating. Trailing yield: 2.4%. Lower than top quartile of British dividend payers (6.1%). In line with average of industry peers (2.2%). Reported Earnings • Mar 25
Full year 2023 earnings released: EPS: €1.80 (vs €1.51 in FY 2022) Full year 2023 results: EPS: €1.80 (up from €1.51 in FY 2022). Revenue: €798.5m (up 13% from FY 2022). Net income: €118.7m (up 19% from FY 2022). Profit margin: 15% (in line with FY 2022). Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Personal Products industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Annuncio • Mar 22
Interparfums SA to Report First Half, 2024 Results on Sep 10, 2024 Interparfums SA announced that they will report first half, 2024 results on Sep 10, 2024 New Risk • Mar 16
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. Cash payout ratio: 168% Dividend yield: 2.2% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Annuncio • Jan 16
Interparfums SA, Annual General Meeting, Apr 16, 2024 Interparfums SA, Annual General Meeting, Apr 16, 2024, at 14:00 Central European Standard Time. Location: Pavillon d’Armenonville, Allée de Longchamp Paris France Annuncio • Oct 19
Interparfums SA to Report Fiscal Year 2023 Results on Feb 28, 2024 Interparfums SA announced that they will report fiscal year 2023 results on Feb 28, 2024 Reported Earnings • Sep 14
First half 2023 earnings released: EPS: €1.12 (vs €0.79 in 1H 2022) First half 2023 results: EPS: €1.12 (up from €0.79 in 1H 2022). Revenue: €396.1m (up 24% from 1H 2022). Net income: €77.6m (up 43% from 1H 2022). Profit margin: 20% (up from 17% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Annuncio • Jul 25
Interparfums SA to Report First Half, 2023 Results on Sep 12, 2023 Interparfums SA announced that they will report first half, 2023 results on Sep 12, 2023 Upcoming Dividend • May 04
Upcoming dividend of €1.05 per share at 1.5% yield Eligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 63% but the company is paying out more than the cash it is generating. Trailing yield: 1.5%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (1.8%). Reported Earnings • Apr 06
Full year 2022 earnings released Full year 2022 results: Revenue: €706.6m (up 26% from FY 2021). Net income: €99.5m (up 40% from FY 2021). Profit margin: 14% (up from 13% in FY 2021). Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Personal Products industry in the United Kingdom. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 8 highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Constance Benque was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Sep 09
First half 2022 earnings released: EPS: €0 (vs €0.73 in 1H 2021) First half 2022 results: EPS: €0. Revenue: €318.7m (up 20% from 1H 2021). Net income: €54.2m (up 19% from 1H 2021). Profit margin: 17% (in line with 1H 2021). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in the United Kingdom. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment improved over the past week After last week's 16% share price gain to €52.30, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 26x in the Personal Products industry in Europe. Total returns to shareholders of 75% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €37.73 per share. Upcoming Dividend • May 09
Upcoming dividend of €0.94 per share Eligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 1.9%. Lower than top quartile of British dividend payers (4.8%). Lower than average of industry peers (2.4%). Reported Earnings • May 05
Full year 2021 earnings released Full year 2021 results: Revenue: €560.8m (up 53% from FY 2020). Net income: €71.1m (up 132% from FY 2020). Profit margin: 13% (up from 8.4% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11%, compared to a 9.0% growth forecast for the industry in the United Kingdom. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 8 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Director Marie-Ange Verdickt was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 09
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €54.80, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 26x in the Personal Products industry in Europe. Total returns to shareholders of 59% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.18 per share. Reported Earnings • Mar 04
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: €560.8m (up 53% from FY 2020). Net income: €71.1m (up 132% from FY 2020). Profit margin: 13% (up from 8.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 6.6%, compared to a 6.0% growth forecast for the industry in the United Kingdom. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improved over the past week After last week's 16% share price gain to €61.75, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 32x in the Personal Products industry in Europe. Total returns to shareholders of 111% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €28.94 per share. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improved over the past week After last week's 16% share price gain to €61.75, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 32x in the Personal Products industry in Europe. Total returns to shareholders of 111% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €28.94 per share. Reported Earnings • Sep 10
First half 2021 earnings released: EPS €0.80 (vs €0.17 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €266.3m (up 91% from 1H 2020). Net income: €45.5m (up 414% from 1H 2020). Profit margin: 17% (up from 6.4% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Upcoming Dividend • Apr 26
Upcoming dividend of €0.55 per share Eligible shareholders must have bought the stock before 03 May 2021. Payment date: 05 May 2021. Trailing yield: 1.0%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (2.1%). Reported Earnings • Mar 27
Full year 2020 earnings released: EPS €0.64 (vs €1.02 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €367.4m (down 24% from FY 2019). Net income: €30.7m (down 39% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Reported Earnings • Mar 03
Full year 2020 earnings released: EPS €0.64 (vs €1.02 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €367.4m (down 24% from FY 2019). Net income: €30.7m (down 39% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Mar 03
Revenue beats expectations Revenue exceeded analyst estimates by 0.02%. Over the next year, revenue is forecast to grow 18% while thePersonal Products industry in the United Kingdom is not expected to grow. Is New 90 Day High Low • Feb 25
New 90-day high: €47.93 The company is up 12% from its price of €42.78 on 26 November 2020. The British market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.00 per share. Is New 90 Day High Low • Feb 03
New 90-day high: €44.63 The company is up 7.0% from its price of €41.83 on 05 November 2020. The British market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.96 per share. Is New 90 Day High Low • Dec 15
New 90-day high: €44.50 The company is up 11% from its price of €40.05 on 16 September 2020. The British market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.38 per share. Is New 90 Day High Low • Nov 05
New 90-day high: €41.83 The company is up 16% from its price of €36.07 on 07 August 2020. The British market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.15 per share. Is New 90 Day High Low • Oct 15
New 90-day high: €41.63 The company is up 16% from its price of €36.00 on 17 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.62 per share. Is New 90 Day High Low • Oct 13
New 90-day high: €41.50 The company is up 12% from its price of €37.07 on 15 July 2020. The British market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.45 per share. 
